NSE · ZYDUSWELL · FMCG
Zydus Wellness Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹133 Cr with net profit ₹13 Cr — a 10.03% net margin, versus 4.97% the period before.
Shareholding
As of 2026-06-30
- Promoter69.64%
- Public7.91%
- FII3.32%
- DII19.14%
86,866 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.66× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Food - Processing - Indian · ranked #3 of 110 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Varun Beverages Limited | ₹1,51,264 Cr | 173.33 | 7.73 | 15.51% | 13.68% |
| Hatsun Agro Product Ltd. | ₹19,727 Cr | 388.42 | 10.15 | 17.97% | 3.62% |
| Zydus Wellness Limited(this company) | ₹18,436 Cr | 113.84 | 3.17 | 3.98% | 5.01% |
| Bikaji Foods International Ltd. | ₹16,094 Cr | 285.27 | 10.01 | 16.07% | 8.8% |
| LT Foods Limited | ₹13,147 Cr | 21.02 | 2.91 | 13.83% | 5.71% |
| Avanti Feeds Limited | ₹12,898 Cr | 103.01 | 3.92 | 18.44% | 9.99% |
| Godrej Agrovet Limited | ₹10,779 Cr | 102.82 | 5.3 | 23.27% | 4.63% |
| Manorama Industries Ltd. | ₹10,389 Cr | 187.24 | 8.79 | 32.97% | 16.58% |
| KRBL Limited | ₹7,978 Cr | 12.31 | 1.37 | 11.16% | 10.63% |
| Orkla India Limited | ₹7,747 Cr | 104.73 | 2.82 | 10.39% | 11.39% |
AI analysis
AI-generated · google/gemini-2.5-flashZydus Wellness Limited has a market capitalization of Rs 19169 Cr. The company reported a revenue of Rs 2722.5 Cr with a revenue growth of 16.4%. Its profit margin stands at 5.01%. The company's 52-week high is Rs 611.85 and its 52-week low is Rs 367.55.
Positives
- +The promoter holding is high at 69.6356% as of June 30, 2026.
- +The debt-to-equity ratio is low at 0.29.
- +The company demonstrated revenue growth of 16.4% to Rs 2722.5 Cr.
Negatives
- −The Price-to-Earnings (P/E) ratio is high at 83.8.
- −The profit margin is relatively low at 5.01%.
- −Net profit in the September 2025 quarter was negative at Rs -52.8 Cr.
- −Net profit in the December 2025 quarter was negative at Rs -39.9 Cr.
Financial performance
Zydus Wellness Limited recorded a revenue of Rs 2722.5 Cr, showing a growth of 16.4%. The profit margin for the company was 5.01%. In the quarter ending March 2026, the company reported a revenue of Rs 1484.7 Cr and a net profit of Rs 162 Cr. However, the quarter ending December 2025 saw a net loss of Rs -39.9 Cr on a revenue of Rs 964.9 Cr.
Profitability & returns
The company's earnings per share (EPS) are Rs 7.19. The return on equity (ROE) is 398.4% and the return on capital employed (ROCE) is 4.0711%. The profit margin for the company was 5.01%. In the December 2025 quarter, the company reported a net profit of -39.9 Cr, following a net profit of -52.8 Cr in the September 2025 quarter.
Balance sheet
Zydus Wellness Limited has a debt-to-equity ratio of 0.29, indicating a relatively low reliance on debt financing. The book value per share is Rs 183.12. The company's market capitalization is Rs 19169 Cr. No specific details about long-term assets or liabilities were provided.
Ownership & pledges
The public shareholding stands at 7.91329999999999%. There are no promoter shares reported as pledged.
Regulatory & surveillance
The company is not currently listed under any surveillance measures. There is no information provided about any regulatory actions or concerns for Zydus Wellness Limited. There are no pledges reported by the promoters.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.